- Astral shares rally 10% following Q1 results; Citi sees target price at Rs 1,900, Nuvama upgrades stock to 'Buy'
Astral shares surged nearly 10% after strong Q1 FY27 results, with profit rising 51.8% YoY. Citi retained a Buy rating with a Rs 1,900 targ...
Listed developers eye Rs 1.82 lakh crore pre-sales in FY27 as housing demand holds firm: ReportLeading Indian developers anticipate substantial pre-sales growth in fiscal year twenty twenty-seven. Combined pre-sales are projected to r...
Listed developers’ pre-sales set to jump 22% to ₹1.82 lakh crore in FY27India’s top listed developers are set to post 22.3% growth in combined pre-sales to ₹1.82 lakh crore in FY27 from ₹1.49 lakh crore, Anarock...
India's 'BBB-' rating unchanged: Fitch cites energy shocks, fiscal weakness, but praises growthFitch Ratings kept India's sovereign credit rating at BBB- with a stable outlook. Robust growth and solid external finances balance fiscal ...
Jubilant Pharmova shares decline 6% after Q1 profits falls 45% YoYJubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decl...
Fitch affirms India's 'BBB-' credit rating with stable outlookFitch Ratings affirmed India’s BBB- long-term rating with a stable outlook and F3 short-term rating, saying macroeconomic stability and imp...
India growth seen slowing to 6.6% in FY27, says Fitch Group company BMIFitch Group’s BMI expects India’s economic growth to slow to6.6% in FY27, from 7.7% in FY26, as the boost from last year’s GST reforms fade...
Lumax Auto Technologies shares rally 19% after Q1 earningsLumax Auto Technologies shares surged after Q1 profit jumped 83% YoY to Rs 99 crore, while revenue grew 33% to Rs 1,364 crore. EBITDA rose ...
Oil India shares jump over 5%. What made Emkay upgrade the stock after Q1 resultsOil India shares jumped over 5% after strong Q1FY27 results prompted Emkay Global to upgrade the stock to ‘Buy’. The brokerage cited attrac...
Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth promp...
Kaynes Tech shares crash 8% after weak Q1 results: What are Nomura and Motilal Oswal sayingKaynes Technology shares tanked 8% after the electronics manufacturing services firm reported a 24.4% YoY decline in Q1 FY27 net profit to ...
Hitachi Energy India Q1 Results: Net profit rises over twofold to Rs 294 croreHitachi Energy India has displayed remarkable financial growth with a net profit soaring over 100% in the June quarter. The company reporte...
Emcure Pharma net profit up 36% at Rs 292 croreEmcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivi...
Kotak sees India posting BoP surplus in FY27; expects 50 bps rate hike in second halfIndia anticipates a balance of payments surplus in FY27. Stronger capital inflows and higher foreign direct investment will support this po...
India's economic growth may moderate in H2FY27, accelerate to 7.2% in FY28: ReportIndia's economic growth will likely moderate in the second half of FY27. Growth may strengthen to around 7.2 per cent in FY28, says ICICI B...
RBI holds repo rate at 5.25%, raises FY27 growth forecast, cuts inflation outlookThe RBI kept the repo rate unchanged at 5.25% for the fourth straight policy review, retained its neutral stance, raised its FY27 growth fo...
RBI GDP Growth 2026-27: Malhotra & Co lift FY27 GDP forecast to 6.7% from 6.6% on growth resilienceRBI GDP Growth 2026: The Reserve Bank of India raised its FY27 GDP growth forecast to 6.7 percent. It kept the policy repo rate unchanged a...